CORONA VIRUS VACCINES MARKET ANALYSIS

1. Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ CORONA VIRUS VACCINES MARKET ANALYSIS

2. CORONA VIRUS VACCINES MARKET ANALYSIS • Corona Virus Vaccine Market, by Vaccine Type (Inactivated Virus, Protein Subunit, Non-replicating Viral Vector, Repurposed Vaccines, RNA Vaccine, DNA Vaccine, and Genetic Vaccines), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

3. The coronavirus disease (COVID-19) pandemic is the most recent outbreak, which was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared coronavirus disease (COVID-19) as a pandemic on March 11, 2020. COVID-19 is a viral infection caused by a coronavirus called SARS-CoV-2, which affects the respiratory tract. The COVID-19 virus is highly contagious and can be transmitted through direct contact with the infected person or an indirect contact with surfaces in the immediate environment. Moreover, the number of people getting infected by COVID-19 has dynamically increased, making it a global pandemic. For instance, according to the Coronavirus Disease (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 57.8 million cases and 1.3 million deaths due to coronavirus disease (COVID-19) were reported up till November 22, 2020 across the globe. • The skyrocketing cases of COVID-19 across the globe have enunciated the need for COVID-19 vaccines, in order to control the spread and combat the pandemic situation. For instance, according to the World Health Organization (WHO), as of 12 November 2020, around 48 vaccines are under clinical evaluation, out of which 10 vaccine candidates are in Phase 3 clinical trials. The details of those 10 vaccines are provided in table below:

5. Moreover, global organizations are providing funding, in order to ensure large scale distribution of COVID-19 vaccines once they are approved by the regulatory authorities. For instance, on October 13, 2020, The World Bank approved around US$ 12 billion for developing countries to finance the purchase and distribution of COVID-19 vaccines, tests, as well as treatment. • The global corona virus vaccine market is estimated to be valued at US$ 14.5 billion in 2021 and is expected to exhibit a CAGR of 30.9% during the forecast period (2021-2027).

6. Figure 1. Global Corona Virus Vaccine Market Share (%) in terms of Value, By Region, 2021

7. Increasing incidence COVID-19 cases is expected to propel the market growth during the forecast period • The increasing number of COVID-19 cases is escalating demand for vaccines, which is expected to boost growth of the global corona virus vaccine market over the forecast period. For instance, according to the Coronavirus Disease (COVID-19) weekly epidemiological update by the World Health Organization (WHO), the coronavirus disease (COVID-19) cases in different regions reported as of November 22, 2020 are as follows:

9. Increasing research and development activities for COVID-19 vaccine is expected to drive the market growth during the forecast period • The demand for COVID-19 vaccine has increased worldwide due to the disease outbreak, which is expected to drive the growth of the global corona virus vaccine market during the forecast period. For instance, on November 16, 2020, Moderna, Inc., announced that the Phase 3 trial of its vaccine candidate mRNA-1273 against COVID-19, has showed efficacy of 94.5%. Moreover, on November 25, 2020, the European Commission entered into an agreement with Moderna, Inc., to purchase up to 160 million doses of their future vaccine for corona virus. 

10. Global Corona Virus Vaccine Market: Restraint • Stringent regulations by the regulatory authorities such U.S. Food and Drug Administration (FDA) have delayed the approval and launches of vaccines for corona virus, which is expected to hinder the market growth over the forecast period. • Key Players • Major players operating in the global corona virus vaccine market include AstraZeneca plc, Pfizer Inc., Sanofi S.A., Novavax, Inc., Moderna, Inc., Sinovac Biotech Ltd., Bharat Biotech International Limited, Johnson & Johnson, BioNTech SE, Serum Institute of India, Shanghai Fosun Pharmaceutical Group Co., Ltd., CanSino Biologics Inc., CureVac AG, Cadila Healthcare Limited, Arcturus Therapeutics Holdings Inc., Entos Pharmaceuticals, and Symvivo.

11. Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst • CMI Services • CMI Latest Insights • CMI Blogs • CMI Press Releases

12. About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

13. Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

14. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/